Scott Zamvil is a Neurology physician affiliated with University of California, San Francisco. OpenAlex indexes 313 publications with 23,654 citations (h-index 72); ClinicalTrials.gov lists 1 registered study matched to this name. By OpenAlex citation count, this profile ranks in the top 10% of Neurology profiles in the findmyKOL directory.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
350 Parnassus Ave
San Francisco, CA 941430001
Telephone
415-514-1684Registry record last updated 10 Jun 2008.
Clinical trials
- Anti-Inflammatory Type II Monocyte Induction by Glatiramer Acetate (Copaxone) Treatment of Multiple Sclerosis
Sponsor: University of California, San Francisco
- Atorvastatin (Lipitor) Therapy in Patients With Clinically Isolated Syndrome (CIS) at Risk for Multiple Sclerosis
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
18 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Novartis Pharmaceuticals CorporationProgram year20253 payments
- Amgen Inc.Program year20253 payments
- Alexion Pharmaceuticals, Inc.Program year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
48.8%Other immunostimulants10.6%Glatiramer Acetate100%Part D<11 patientsPyrimidine Synthesis Inhibitor9.4%Aubagio100%Part D<11 patients+ 4 more classes in this area
Nervous system
35.6%Sympathomimetic-like Agent10.6%Modafinil100%Part D<11 patientsAminoketone8.8%Bupropion Hcl Sr100%Part D<11 patients+ 2 more classes in this area
Musculoskeletal
15.6%gamma-Aminobutyric Acid-ergic Agonist15.6%Baclofen100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
10 NIH research awards on record, funded 1998–2026 per NIH RePORTER. The latest:
- Characterization of T cells in MOG antibody-associated disease
University of California, San Francisco
FY2026$796,129R01AI170863 - Characterization of T cells in MOG antibody-associated disease
University of California, San Francisco
FY2025$798,080R01AI170863 - Characterization of T cells in MOG antibody-associated disease
University of California, San Francisco
FY2024$799,627R01AI170863
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Spinal Cord Atrophy Predicts Progressive Disease in Relapsing Multiple Sclerosis
Annals of Neurology
2021 - A pathogenic and clonally expanded B cell transcriptome in active multiple sclerosis
Proceedings of the National Academy of Sciences
2020
Similar KOLs
Other experts from the same institution or the same specialty.
Kristine Yaffe, MD
University of California, San Francisco
Peter Carroll, MD
University of California, San Francisco
Mitchel Berger, MD
University of California, San Francisco
Elyse Foster, MD
University of California, San Francisco
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”